{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:14:32Z","timestamp":1789571672531,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["No. 23JCYBJC00700"],"award-info":[{"award-number":["No. 23JCYBJC00700"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04594-z","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:46:40Z","timestamp":1749188800000},"page":"3909-3915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effects of GLUT9 and URAT1 inhibitors on cardiovascular diseases: a drug-targeted Mendelian randomization study"],"prefix":"10.1007","volume":"57","author":[{"given":"Qian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"8","key":"4594_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","volume":"116","author":"HK Choi","year":"2007","unstructured":"Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116(8):894\u2013900","journal-title":"Circulation"},{"issue":"6","key":"4594_CR2","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard.2009.122770","volume":"69","author":"MA De Vera","year":"2010","unstructured":"De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK (2010) Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis 69(6):1162\u20131164","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4594_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s40265-019-01081-5","volume":"79","author":"MK Gupta","year":"2019","unstructured":"Gupta MK, Singh JA (2019) Cardiovascular disease in gout and the protective effect of treatments including urate-lowering therapy. Drugs 79(5):531\u2013541","journal-title":"Drugs"},{"issue":"5","key":"4594_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/jama.2022.11390","volume":"328","author":"E Cipolletta","year":"2022","unstructured":"Cipolletta E, Tata LJ, Nakafero G, Avery AJ, Mamas MA, Abhishek A (2022) Association between gout flare and subsequent cardiovascular events among patients with gout. JAMA 328(5):440\u2013450","journal-title":"JAMA"},{"issue":"9","key":"4594_CR5","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3899\/jrheum.141542","volume":"42","author":"JH Chen","year":"2015","unstructured":"Chen JH, Lan JL, Cheng CF, Liang WM, Lin HY, Tsay GJ, Yeh WT, Pan WH (2015) Effect of urate-lowering therapy on the risk of cardiovascular disease and all-cause mortality in patients with gout: a case-matched cohort study. J Rheumatol 42(9):1694\u20131701","journal-title":"J Rheumatol"},{"issue":"12","key":"4594_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/13543776.2022.2165911","volume":"32","author":"X Shi","year":"2022","unstructured":"Shi X, Zhao T, da Silva-Junior EF, Zhang J, Xu S, Gao S, Liu X, Zhan P (2022) Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020-present). Expert Opin Ther Pat 32(12):1175\u20131184","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"4594_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/ki.2010.206","volume":"78","author":"AF Wright","year":"2010","unstructured":"Wright AF, Rudan I, Hastie ND, Campbell H (2010) A \u2018complexity\u2019 of urate transporters. Kidney Int 78(5):446\u2013452","journal-title":"Kidney Int"},{"key":"4594_CR8","doi-asserted-by":"publisher","first-page":"1759720X2211164","DOI":"10.1177\/1759720X221116409","volume":"14","author":"Y Eun","year":"2022","unstructured":"Eun Y, Han H, Kim K, Kang S, Lee S, Kim H, Lee J, Koh EM, Cha HS (2022) Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout. Ther Adv Musculoskelet Dis 14:1759720X221116409","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"4594_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","volume":"3","author":"K Ogino","year":"2010","unstructured":"Ogino K, Kato M, Furuse Y, Kinugasa Y, Ishida K, Osaki S, Kinugawa T, Igawa O, Hisatome I, Shigemasa C et al (2010) Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 3(1):73\u201381","journal-title":"Circ Heart Fail"},{"issue":"9","key":"4594_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamacardio.2022.2333","volume":"7","author":"AJ Cupido","year":"2022","unstructured":"Cupido AJ, Reeskamp LF, Hingorani AD, Finan C, Asselbergs FW, Hovingh GK, Schmidt AF (2022) Joint genetic inhibition of PCSK9 and CETP and the association with coronary artery disease: a factorial Mendelian randomization study. JAMA Cardiol 7(9):955\u2013964","journal-title":"JAMA Cardiol"},{"issue":"7","key":"4594_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.numecd.2023.04.007","volume":"33","author":"Y Li","year":"2023","unstructured":"Li Y, Xiao W, Huang N, Zhuang Z, Zhang L, Wang W, Song Z, Zhao Y, Dong X, Xu M et al (2023) The effects of blood pressure and antihypertensive drugs on heart failure: a Mendelian randomization study. Nutr Metab Cardiovasc Dis 33(7):1420\u20131428","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"4594_CR12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","volume":"51","author":"A Tin","year":"2019","unstructured":"Tin A, Marten J, Halperin Kuhns VL, Li Y, Wuttke M, Kirsten H, Sieber KB, Qiu C, Gorski M, Yu Z et al (2019) Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels. Nat Genet 51(10):1459\u20131474","journal-title":"Nat Genet"},{"issue":"4","key":"4594_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s43587-021-00051-5","volume":"1","author":"HM Donertas","year":"2021","unstructured":"Donertas HM, Fabian DK, Valenzuela MF, Partridge L, Thornton JM (2021) Common genetic associations between age-related diseases. Nat Aging 1(4):400\u2013412","journal-title":"Nat Aging"},{"issue":"1","key":"4594_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, Lin H, Sveinbjornsson G, Fatemifar G, Hedman AK, Wilk JB, Morley MP, Chaffin MD et al (2020) Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun 11(1):163","journal-title":"Nat Commun"},{"issue":"10","key":"4594_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, Narita A, Konuma T, Yamamoto K, Akiyama M et al (2021) A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53(10):1415\u20131424","journal-title":"Nat Genet"},{"issue":"6","key":"4594_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen J, Spracklen CN, Marenne G, Varshney A, Corbin LJ, Luan J, Willems SM, Wu Y, Zhang X, Horikoshi M et al (2021) The trans-ancestral genomic architecture of glycemic traits. Nat Genet 53(6):840\u2013860","journal-title":"Nat Genet"},{"issue":"7","key":"4594_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41588-018-0144-6","volume":"50","author":"PR Loh","year":"2018","unstructured":"Loh PR, Kichaev G, Gazal S, Schoech AP, Price AL (2018) Mixed-model association for biobank-scale datasets. Nat Genet 50(7):906\u2013908","journal-title":"Nat Genet"},{"issue":"7890","key":"4594_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","volume":"600","author":"SE Graham","year":"2021","unstructured":"Graham SE, Clarke SL, Wu KH, Kanoni S, Zajac GJM, Ramdas S, Surakka I, Ntalla I, Vedantam S, Winkler TW et al (2021) The power of genetic diversity in genome-wide association studies of lipids. Nature 600(7890):675\u2013679","journal-title":"Nature"},{"issue":"11","key":"4594_CR19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/eurjpc\/zwac100","volume":"29","author":"F Yang","year":"2022","unstructured":"Yang F, Hu T, Cui H (2022) Serum urate and heart failure: a bidirectional Mendelian randomization study. Eur J Prev Cardiol 29(11):1570\u20131578","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"4594_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12967-023-04307-z","volume":"21","author":"Y Han","year":"2023","unstructured":"Han Y, Cao Y, Han X, Di H, Yin Y, Wu J, Zhang Y, Zeng X (2023) Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey. J Transl Med 21(1):463","journal-title":"J Transl Med"},{"issue":"7","key":"4594_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/03007995.2023.2223916","volume":"39","author":"J Ke","year":"2023","unstructured":"Ke J, Pan J, Lin H, Han Z, Gu J (2023) Uric acid-lowering therapy with benzbromarone in hypertension with asymptomatic hyperuricemia: a randomized study focusing left ventricular diastolic function. Curr Med Res Opin 39(7):947\u2013953","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"4594_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s40001-023-01208-1","volume":"28","author":"A Tanaka","year":"2023","unstructured":"Tanaka A, Taguchi I, Hisauchi I, Yoshida H, Shimabukuro M, Hongo H, Ishikawa T, Kadokami T, Yagi S, Sata M et al (2023) Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA). Eur J Med Res 28(1):238","journal-title":"Eur J Med Res"},{"issue":"2","key":"4594_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/biomedicines11020567","volume":"11","author":"H Yanai","year":"2023","unstructured":"Yanai H, Katsuyama H, Hakoshima M, Adachi H (2023) Urate transporter 1 can be a therapeutic target molecule for chronic kidney disease and diabetic kidney disease: a retrospective longitudinal study. Biomedicines 11(2):567","journal-title":"Biomedicines"},{"issue":"9","key":"4594_CR24","doi-asserted-by":"publisher","first-page":"107730","DOI":"10.1016\/j.isci.2023.107730","volume":"26","author":"Y Tanaka","year":"2023","unstructured":"Tanaka Y, Nagoshi T, Takahashi H, Oi Y, Yasutake R, Yoshii A, Kimura H, Kashiwagi Y, Tanaka TD, Shimoda M et al (2023) URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease. iScience 26(9):107730","journal-title":"iScience"},{"issue":"17","key":"4594_CR25","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","volume":"22","author":"H Yanai","year":"2021","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H (2021) Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci 22(17):9221","journal-title":"Int J Mol Sci"},{"key":"4594_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2025.154070","volume":"511","author":"K Zhao","year":"2025","unstructured":"Zhao K, Zhang S, Tian J, Wu S, Chen Y, Wu Z, Liang J, Wu H, Pang J, Wu T (2025) Loss of Urat1 exacerbates APAP-induced liver injury in mice. Toxicology 511:154070","journal-title":"Toxicology"},{"issue":"10","key":"4594_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050197","volume":"5","author":"MJ Caulfield","year":"2008","unstructured":"Caulfield MJ, Munroe PB, O\u2019Neill D, Witkowska K, Charchar FJ, Doblado M, Evans S, Eyheramendy S, Onipinla A, Howard P et al (2008) SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5(10):e197","journal-title":"PLoS Med"},{"issue":"5","key":"4594_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ki.2011.414","volume":"81","author":"A Parsa","year":"2012","unstructured":"Parsa A, Brown E, Weir MR, Fink JC, Shuldiner AR, Mitchell BD, McArdle PF (2012) Genotype-based changes in serum uric acid affect blood pressure. Kidney Int 81(5):502\u2013507","journal-title":"Kidney Int"},{"issue":"5","key":"4594_CR29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67(5):1739\u20131742","journal-title":"Kidney Int"},{"issue":"7","key":"4594_CR30","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0735-1097(01)01643-6","volume":"38","author":"AJ Maxwell","year":"2001","unstructured":"Maxwell AJ, Bruinsma KA (2001) Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 38(7):1850\u20131858","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4594_CR31","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/s12072-022-10371-2","volume":"16","author":"H Zeng","year":"2022","unstructured":"Zeng H, Tang C, Lin B, Yu M, Wang X, Wang J, Chen S, Yu C (2022) The regulation effect of GLUT9\/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease. Hepatol Int 16(5):1064\u20131074","journal-title":"Hepatol Int"},{"issue":"12","key":"4594_CR32","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s00424-018-2190-4","volume":"470","author":"M Auberson","year":"2018","unstructured":"Auberson M, Stadelmann S, Stoudmann C, Seuwen K, Koesters R, Thorens B, Bonny O (2018) SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney. Pflugers Arch 470(12):1739\u20131751","journal-title":"Pflugers Arch"},{"issue":"4","key":"4594_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.15406\/jdmdc.2018.05.00148","volume":"5","author":"CJ Tayek","year":"2018","unstructured":"Tayek CJ, Cherukuri L, Hamal S, Tayek JA (2018) Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal. J Diabetes Metab Disord Control 5(4):113\u2013117","journal-title":"J Diabetes Metab Disord Control"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04594-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04594-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04594-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T09:55:58Z","timestamp":1762336558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04594-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4594"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04594-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6055930\/v1","asserted-by":"object"}]},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}